Payden Equity Income Fund Adviser Class
PYVAX
NASDAQ
| Weiss Ratings | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B- | |||
| Company Info | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Paydenfunds | |||
| Manager/Tenure (Years) | James T. Wong (16), Alfred Giles (5), Michael Huynh (5), 1 other | |||
| Website | http://www.payden.com | |||
| Fund Information | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Payden Equity Income Fund Adviser Class | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Equity-Income | |||
| Inception Date | Dec 01, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 5,000.00 | |||
| Minimum Subsequent Investment | 250.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.00% | |||
| Dividend | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.38% | |||
| Asset Allocation | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 8.49% | |||
| Stock | 91.29% | |||
| U.S. Stock | 87.09% | |||
| Non-U.S. Stock | 4.20% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.23% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.67% | |||
| 30-Day Total Return | -0.55% | |||
| 60-Day Total Return | 7.43% | |||
| 90-Day Total Return | 1.23% | |||
| Year to Date Total Return | 0.48% | |||
| 1-Year Total Return | 5.90% | |||
| 2-Year Total Return | 24.32% | |||
| 3-Year Total Return | 31.57% | |||
| 5-Year Total Return | 59.88% | |||
| Price | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $16.19 | |||
| 1-Month Low NAV | $15.94 | |||
| 1-Month High NAV | $16.37 | |||
| 52-Week Low NAV | $14.32 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $20.01 | |||
| 52-Week High Price (Date) | Nov 29, 2024 | |||
| Beta / Standard Deviation | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Standard Deviation | 15.09 | |||
| Balance Sheet | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.00B | |||
| Operating Ratios | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.01% | |||
| Turnover Ratio | 80.00% | |||
| Performance | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 17.42% | |||
| Last Bear Market Total Return | -10.15% | |||